Literature DB >> 1295764

Survey of the susceptibility patterns of Bacteroides fragilis group strains in France from 1977 to 1992.

L Dubreuil1, J Breuil, A Dublanchet, A Sedallian.   

Abstract

Rates of antibiotic resistance within the Bacteroides fragilis group were monitored over a 15-year period in France by examining studies that employed the same methodology to test susceptibility of anaerobic bacteria. Chloramphenicol, metronidazole, beta-lactam/beta-lactamase inhibitor combinations and imipenem remained very active against Bacteroides fragilis. There was little or no change in rates of resistance to these antibiotics. Resistance to clindamycin increased from 1% in 1977 to a peak of 19% in 1987, and since then has remained at 8 to 12%. There was some evidence that resistance to most beta-lactam agents increased during the same period. These results emphasize the need for periodic surveys of resistance patterns of the Bacteroides fragilis group in each country.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1295764     DOI: 10.1007/bf01967804

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  35 in total

Review 1.  Susceptibility testing of anaerobic bacteria: myth, magic, or method?

Authors:  H M Wexler
Journal:  Clin Microbiol Rev       Date:  1991-10       Impact factor: 26.132

2.  Survey of Bacteroides fragilis susceptibility patterns in France.

Authors:  J Breuil; C Burnat; O Patey; A Dublanchet
Journal:  J Antimicrob Chemother       Date:  1989-07       Impact factor: 5.790

3.  Isolation of Bacteroides strains with reduced sensitivity to 5-nitroimidazoles.

Authors:  A Dublanchet; J Caillon; J P Emond; H Chardon; H B Drugeon
Journal:  Eur J Clin Microbiol       Date:  1986-06       Impact factor: 3.267

4.  [Comparative sensitivity of 207 strains of strict anaerobic bacteria to piperacillin and 4 other antibiotics].

Authors:  A Reynaud; H B Drugeon; M Derriennic; A L Courtieu
Journal:  Pathol Biol (Paris)       Date:  1985-11

5.  [In vitro activity of cefotaxime on anaerobes (author's transl)].

Authors:  C J Soussy; M Thibault; J Duval
Journal:  Nouv Presse Med       Date:  1981-02-26

6.  [In vitro sensitivity of strict anaerobic Gram-negative bacilli to thienamycin NF and various cephalosporins].

Authors:  L Dubreuil; J Devos; C Romond
Journal:  Pathol Biol (Paris)       Date:  1984-05

7.  The changing pattern of antibiotic susceptibilities of Bacteroides fragilis in Kuwait.

Authors:  K M Elhag; A K Mustafa; A A Pazhoor
Journal:  J Antimicrob Chemother       Date:  1989-11       Impact factor: 5.790

Review 8.  Evolution in antibiotic susceptibility of Bacteroides fragilis group strains in France based on periodic surveys.

Authors:  L Dubreuil; M Derriennic; A Sedallian; C Romond; A L Courtieu
Journal:  Infection       Date:  1989 May-Jun       Impact factor: 3.553

9.  Belgian Collaborative Study of the in-vitro susceptibility of the Bacteroides fragilis group. A Belgian Collaborative Study Group.

Authors: 
Journal:  Eur J Epidemiol       Date:  1988-09       Impact factor: 8.082

10.  [In vitro effect of piperacillin, amoxicillin, cefoxitin and metronidazole against obligate anaerobic bacteria].

Authors:  M Derriennic; A Reynaud; C Launay; A L Courtieu
Journal:  Presse Med       Date:  1986-12-20       Impact factor: 1.228

View more
  4 in total

1.  Decreased susceptibility to nitroimidazoles among Bacteroides species in Brazil.

Authors:  Jessica Manya B D Vieira; Renata F Boente; Karla Rodrigues Miranda; Kátia E S Avelar; Regina M C P Domingues; Maria Candida de S Ferreira
Journal:  Curr Microbiol       Date:  2005-12-26       Impact factor: 2.188

2.  In vitro evaluation of activities of nitazoxanide and tizoxanide against anaerobes and aerobic organisms.

Authors:  L Dubreuil; I Houcke; Y Mouton; J F Rossignol
Journal:  Antimicrob Agents Chemother       Date:  1996-10       Impact factor: 5.191

3.  Susceptibility testing of anaerobic bacteria: evaluation of the redesigned (Version 96) bioMérieux ATB ANA device.

Authors:  L Dubreuil; I Houcke; E Singer
Journal:  J Clin Microbiol       Date:  1999-06       Impact factor: 5.948

4.  In vitro activities of a new des-fluoro(6) quinolone, garenoxacin, against clinical anaerobic bacteria.

Authors:  A Liebetrau; A C Rodloff; J Behra-Miellet; L Dubreuil
Journal:  Antimicrob Agents Chemother       Date:  2003-11       Impact factor: 5.191

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.